about
Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational studyInternational health research monitoring: exploring a scientific and a cooperative approach using participatory action researchMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy numberInhaled azithromycin therapy.Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.Artemisinin resistance--modelling the potential human and economic costs.In vivo parasitological measures of artemisinin susceptibilityA small amount of fat does not affect piperaquine exposure in patients with malaria.Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infectionsPerformance of a histidine-rich protein 2 rapid diagnostic test, Paracheck Pf®, for detection of malaria infections in Ugandan pregnant womenA major genome region underlying artemisinin resistance in malariaIdentification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department.Population genetic correlates of declining transmission in a human pathogenThe relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria.Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies.Population Parameters Underlying an Ongoing Soft Sweep in Southeast Asian Malaria Parasites.Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.Alternative therapies for Clostridium difficile infections.Effect of colistin on phospholipid-based activated partial thromboplastin time clotting assay results in patients receiving concomitant heparin therapy.Antimicrobial stewardship: a matter of process or outcome?Antimicrobial stewardship: another focus for patient safety?Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice.Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazoleWe still need artesunate monotherapyComparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia.Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options.Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures.A case-control auditory evaluation of patients treated with artemether-lumefantrine.Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition.What’s Next? Sustaining Hospital-Initiated Nursing Home Antimicrobial Stewardship Programs.Inpatient plus Post-discharge Durations of Therapy to Identify Antimicrobial Stewardship Opportunities at Transitions of Care.Benchmarking Antimicrobial Use in Emergency Departments among Community Hospitals in the Duke Antimicrobial Stewardship Outreach Network.Seasonal variation in hyperparasitaemia and gametocyte carriage in patients with Plasmodium falciparum malaria on the Thai-Burmese border.Malaria misconceptions.Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
P50
Q28487636-A5488005-152D-440C-8BED-69F0B7C5AE40Q28658944-9B3D44F0-25C0-4019-931F-BFBBAD19D91BQ29615128-72AB9AA9-090F-4E2F-9FDA-87E5DCB64D26Q33237163-2C35B4CB-CB65-44E7-B793-566AB49793FAQ33622892-6B4E661E-DD06-466A-AFD0-060A67DD4252Q34164652-BC6CAD53-62EA-4885-A95F-DC30D7319FA7Q34623414-BA7CA754-9676-4038-A56A-72E2F8599E76Q34921155-9EB0377F-BCE9-49D9-9012-724971802AA4Q35191426-1BD13B24-FBB1-4CC1-BFCF-7DAA779E6760Q35598469-A4245063-5A31-4512-B39A-6CDACAF4360FQ35637028-AA527BFC-36E7-4DF5-9699-B3D0135B6A09Q35969854-BF035B72-3214-4EF5-8129-9DDB042482E3Q36432975-A766A844-B89F-4E2A-910E-6AA97B69A402Q36497838-0549BC64-360E-44B4-87AB-BC51EADB41C1Q36510939-4FB50089-A692-4232-8368-0A7AEA857E7EQ36836624-C1F5CF6B-E527-4968-BF59-D3783145082AQ37325655-8A85DA79-3CEA-4D87-A8DB-942EE1FCCB49Q37564232-A0DB3FE8-2FF1-430E-9762-D6AD50E3DF1AQ37760514-919F30C1-7E0D-47F9-8B29-042854CD375BQ37813126-2159591E-5C59-4AC4-8D08-09E7B583DB70Q37848401-111480AC-D2EF-414B-AB36-7E62AA89969AQ38073196-83DE0AA0-EDBC-46DB-A9A9-5DE61583FDDFQ38221561-CB454693-E8E3-4AB3-B421-8B327985827BQ38875347-F1B559E9-AC4D-4F2F-BAFE-73AEE71BB875Q40638495-A0F357DD-733C-4E52-9763-4DDD93590903Q42374811-4FB4FB67-24A0-445B-9F8B-7996469C7E10Q44741814-E5F58860-C06D-4A27-844C-8BC30700672AQ45152117-0EEA047C-E69F-4107-92A9-5E05E5731D6BQ45746822-726ADC7B-B9B4-4E25-8529-D221590832FEQ45861947-15BE5E4F-6673-4032-BBB5-7156EE951EFDQ46934764-E6106B38-8E49-4728-9561-67C19627F4E5Q46941167-24C527D8-450A-4326-ADBC-7213D37C2508Q47095541-2FFA8CC7-78FC-4FFB-850A-3591D23FD533Q47107068-F778CCE9-133B-4F98-8992-CECDA0A08001Q47149060-995922B9-C6E1-4A1B-B9F0-3E3BD181BA29Q47160533-1BD5397C-C50A-4E5E-A96D-87208F47EFF7Q47985039-7B20DEFB-E266-46D4-9D7E-92D92F0A294AQ48004143-8219B203-9AC3-410D-9192-38FC55742BE2Q48031726-64F7968E-D05E-4F80-8665-9FD43B5A2593Q48037077-762180B4-B18E-4FC4-B18A-0B82EC9EF176
P50
name
Elizabeth Dodds Ashley
@en
type
label
Elizabeth Dodds Ashley
@en
prefLabel
Elizabeth Dodds Ashley
@en